Prenetics Global Limited

NasdaqGM:PRE Stock Report

Market Cap: US$300.6m

Prenetics Global Management

Management criteria checks 1/4

Prenetics Global's CEO is Danny Yeung, appointed in Jan 2014, has a tenure of 12.5 years. directly owns 10.22% of the company’s shares, worth $30.71M. The average tenure of the management team and the board of directors is 2.5 years and 2.4 years respectively.

Key information

Danny Yeung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.5yrs
CEO ownership10.2%
Management average tenure2.5yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Seeking Alpha • Apr 18

Prenetics Global: On Course To Hit Profitability Amid Globalization Drive

Summary Prenetics Global Limited (PRE) remains a buy, with a 15% near-term and 60% 24-month upside potential based on robust revenue growth projections. PRE’s strategic focus on IM8, divestiture of non-core assets, and global partnerships underpin its growth and profitability trajectory through 2027. Liquidity is strong with $100M cash and no debt, reducing dilution risk as PRE targets profitability by Q4 2027. AI-driven cost optimization and celebrity-backed marketing are expected to enhance margins and global brand reach, supporting PRE’s revenue and margin expansion goals. Read the full article on Seeking Alpha
Analysis Article • Jan 30

Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 30% Share Price Bounce

Despite an already strong run, Prenetics Global Limited ( NASDAQ:PRE ) shares have been powering on, with a gain of 30...
Analysis Article • Sep 09

Market Participants Recognise Prenetics Global Limited's (NASDAQ:PRE) Revenues Pushing Shares 27% Higher

Prenetics Global Limited ( NASDAQ:PRE ) shares have had a really impressive month, gaining 27% after a shaky period...
Analysis Article • May 11

Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce

Prenetics Global Limited ( NASDAQ:PRE ) shares have had a really impressive month, gaining 50% after a shaky period...
Analysis Article • Mar 27

What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash

To the annoyance of some shareholders, Prenetics Global Limited ( NASDAQ:PRE ) shares are down a considerable 27% in...
Analysis Article • Dec 16

Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce

Prenetics Global Limited ( NASDAQ:PRE ) shareholders have had their patience rewarded with a 32% share price jump in...
Analysis Article • Oct 12

Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors

When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...
Analysis Article • May 29

Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump

Prenetics Global Limited ( NASDAQ:PRE ) shareholders would be excited to see that the share price has had a great...
Analysis Article • Apr 08

Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues

The Prenetics Global Limited ( NASDAQ:PRE ) share price has fared very poorly over the last month, falling by a...
Analysis Article • Jan 07

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Prenetics Global Limited ( NASDAQ:PRE ) shareholders are no doubt pleased to see that the share price has bounced 30...
Seeking Alpha • Sep 09

Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M

Prenetics Global press release (NASDAQ:PRE): Q2 GAAP EPS of -$2.91. Revenue of $51.72M (-34.5% Y/Y). Adjusted EBITDA  of $6.5M Raises full year adjusted EBITDA guidance to the range of US$35 million to US$45 million, with corresponding full year revenue guidance in the range of US$255 million to US$275 million

CEO

Danny Yeung (47 yo)

12.5yrs
Tenure

Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chief Executive Officer and Director at Prenetics Global Limited since 2014 and serves as its Chairman. He served as Founding Partner at SXE V...

Leadership Team

NamePositionTenureCompensationOwnership
Sheng Wu Yeung
Co-Founder12.5yrsno data10.22%
$ 30.7m
Samantha Kwok
Chief of Staff & VP of People & Operations3.5yrsno datano data
Senthil Kumar Sundaram
Chief Clinical Officerno datano datano data
James DiNicolantonio
Chief Nutrition Officer1.5yrsno datano data
Brian Rosin
Chief Financial Officer of U.S.less than a yearno datano data
2.5yrs
Average Tenure

Experienced Management: PRE's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sheng Wu Yeung
Co-Founder12.5yrsno data10.22%
$ 30.7m
James DiNicolantonio
Chief Nutrition Officer1.5yrsno datano data
Pan-Chyr Yang
Member of Scientific & Medical Advisory Board3.3yrsno datano data
Pasi Antero Janne
Member of Scientific & Medical Advisory Board3.3yrsno datano data
Shu Mok
Chairman of Scientific Advisory Board3.3yrsno datano data
Yin Pan Cheng
Independent Directorno datano data0.35%
$ 1.1m
Suzanne Devkota
Member of Scientific & Medical Advisory Boardno datano datano data
Darshan Shah
Independent Director & Member of Scientific and Medical Advisory Board1.5yrsno data0.027%
$ 80.5k
James L. Green
Member of Scientific Advisory Board2.4yrsno datano data
Dawn Mussallem
Member of Scientific & Medical Advisory Boardno datano datano data
Amy Shah
Member of Scientific and Medical Advisory Board1.3yrsno datano data
Simon Hill
Member of Scientific & Medical Advisory Board1.5yrsno datano data
2.4yrs
Average Tenure
50yo
Average Age

Experienced Board: PRE's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 23:30
End of Day Share Price 2026/07/13 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Prenetics Global Limited is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William SutherlandBenchmark Company
Ryan MeyersLake Street Capital Markets, LLC
George KellyRoth Capital Partners